Goals and Objectives

The main goal of this group is to thoroughly identify proteins/metabolites that result from alterations in biological processes associated with non-communicable diseases but also against important infectious diseases such as COVID-19
Contribute to a better understanding of the underlying mechanisms of diseases through the application of large-scale proteomics and metabolomics.
Optimization of large-scale data analysis and downstream computational, bioinformatics analysis and machine learning.
Consistently verification and translational of identified disease biomarkers through the application of MS-based quantitative measurements.
Developed qualified biomarkers warranty approved by the FDA
Identify new targets for drugs against non-communicable diseases but also against important infectious diseases such as COVID-19
Utilize qualified biomarker(s) to develop and test therapeutic agents against Human diseases
Development of immunochemistry/colorimetric products for a rapid detection of the qualified biomarkers